These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
104 related items for PubMed ID: 1981319
1. Effect of UK-52,046, an alpha 1-adrenoceptor antagonist, on baroreflex function in man. McKaigue JP, Harron DW. Br J Clin Pharmacol; 1990 Oct; 30(4):579-84. PubMed ID: 1981319 [Abstract] [Full Text] [Related]
2. Duration of action and effect on baroreflex function of the anti-arrhythmic alpha 1 antagonist UK-52,046. Spiers JP, Harron DW, Wilson R. J Pharm Pharmacol; 1991 Jan; 43(1):70-2. PubMed ID: 1676070 [Abstract] [Full Text] [Related]
3. UK-52,046 (a novel alpha 1-adrenoceptor antagonist) and the role of alpha-adrenoceptor stimulation and blockade on atrioventricular conduction. Spiers JP, Harron DW, Wilson R, Allen JD. J Cardiovasc Pharmacol; 1990 Nov; 16(5):824-30. PubMed ID: 1703607 [Abstract] [Full Text] [Related]
4. Studies with abanoquil (UK-52,046) a novel quinoline alpha 1-adrenoceptor antagonist: I. Effects on blood pressure, heart rate and pressor responsiveness in normotensive subjects. Schafers RF, Elliott HL, Howie CA, Reid JL. Br J Clin Pharmacol; 1991 Nov; 32(5):599-604. PubMed ID: 1683249 [Abstract] [Full Text] [Related]
5. Dose-dependent alpha 1-adrenoceptor antagonist activity of the anti-arrhythmic drug, abanoquil (UK-52,046), without reduction in blood pressure in man. Tham TC, Guy S, Shanks RG, Harron DW. Br J Clin Pharmacol; 1992 Apr; 33(4):405-9. PubMed ID: 1349492 [Abstract] [Full Text] [Related]
6. The effect of acute and chronic captopril therapy on baroreflex function in man. Kondowe GB, Deering AH, Riddell JG, Johnston GD, Harron DW. Br J Clin Pharmacol; 1988 Mar; 25(3):315-21. PubMed ID: 3129008 [Abstract] [Full Text] [Related]
7. Studies with abanoquil (UK-52,046) a novel quinoline alpha 1-adrenoceptor antagonist: II. Duration of action, pharmacokinetics and concentration-effect relationships in normotensive subjects. Schafers RF, Elliott HL, Meredith PA, Miller SH, Reid JL. Br J Clin Pharmacol; 1991 Nov; 32(5):605-10. PubMed ID: 1683250 [Abstract] [Full Text] [Related]
8. Suppression of reflex tachycardia by central administration of the alpha-1 adrenoceptor antagonists urapidil and prazosin in anesthetized dogs. Shebuski RJ, Zimmerman BG. J Pharmacol Exp Ther; 1985 Aug; 234(2):456-62. PubMed ID: 2862276 [Abstract] [Full Text] [Related]
13. Suppression of reflex tachycardia following alpha-adrenoceptor blockade in conscious dogs: comparison of urapidil with prazosin. Shebuski RJ, Zimmerman BG. J Cardiovasc Pharmacol; 1984 Mar; 6(5):788-94. PubMed ID: 6209481 [Abstract] [Full Text] [Related]
14. Prazosin depression of baroreflex function in hypertensive man. Sasso EH, O'Connor DT. Eur J Clin Pharmacol; 1982 Mar; 22(1):7-14. PubMed ID: 7047170 [Abstract] [Full Text] [Related]
15. Doxazosin, an alpha 1-adrenoceptor antagonist: pharmacokinetics and concentration-effect relationships in man. Vincent J, Elliott HL, Meredith PA, Reid JL. Br J Clin Pharmacol; 1983 Jun; 15(6):719-25. PubMed ID: 6135439 [Abstract] [Full Text] [Related]
16. Antihypertensive drugs and baroreflex sensitivity. Effects of rilmenidine. Harron DW. Am J Med; 1989 Sep 18; 87(3C):57S-62S. PubMed ID: 2506754 [Abstract] [Full Text] [Related]
17. Influence of nifedipine on arterial baroreflex modulation of heart rate control during dynamic increases in arterial pressure: studies in normal man. Ferguson DW. Am Heart J; 1987 Oct 18; 114(4 Pt 1):773-81. PubMed ID: 3661368 [Abstract] [Full Text] [Related]